GlassScriptPhysician profile
David E Mcginnis
NPI 1063538395
$5,537.42
in general payments reported to CMS, 2019-2025
41 companies · $51.47 in 2025
The $51.47 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,839 · 2020: $438 · 2021: $793 · 2022: $455 · 2023: $942 · 2024: $1,019 · 2025: $51.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.50 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,143.22 | 2019-2024 | Provenge |
| Astellas Pharma US INC | $651.52 | 2019-2024 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $613.60 | 2019-2023 | Erleada |
| Karl Storz Endoscopy-America | $345.01 | 2019-2020 | |
| Boston Scientific Corporation | $266.74 | 2019-2024 | Lithovue, Spaceoar Vue System - 10ml, Spaceoar System |
| Pfizer INC. | $200.02 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $171.22 | 2019 | |
| Coloplast Corp | $149.31 | 2019-2024 | |
| Amgen INC. | $144.72 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $143.01 | 2024 | Erleada |
| Merck Sharp & Dohme LLC | $142.53 | 2020-2024 | Lynparza, Keytruda, Welireg |
| Abbvie INC. | $141.29 | 2020-2024 | |
| Medtronic, INC. | $137.06 | 2021-2023 | Interstim |
| Progenics Pharmaceuticals, INC. | $134.99 | 2023-2024 | Pylarify |
| Astrazeneca Pharmaceuticals LP | $129.35 | 2019-2025 | Lynparza, Imfinzi |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcginnis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.